1550.6000 -32.55 (-2.06%)
NSE Apr 04, 2025 15:31 PM
Volume: 71,847
 

1550.60
-2.06%
Emkay
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
Metropolis Healthcare Ltd. is trading below all available SMAs
More from Metropolis Healthcare Ltd.
Recommended